Samil Pharm (000520) — Long-term Investment Intensity

Latest as of December 2019: 0.6%

Samil Pharm (000520) has a Long-term Investment Intensity of 0.6% as of December 2019. Long-term investments of ₩1.03 Billion represent 0.6% of total assets of ₩183.87 Billion. A higher ratio indicates a company with significant capital committed to long-duration strategic positions. Check Samil Pharm asset resilience ratio to evaluate the company's liquid asset resilience ratio.

LT Investment Intensity

0.6%
LT Investments / Total Assets

Long-term Investments

₩1.03 Billion
KRW

Total Assets

₩183.87 Billion
KRW

Country

Korea
KO

Samil Pharm Long-term Investment Intensity (2013–2019)

This chart shows how Samil Pharm's Long-term Investment Intensity has evolved across 7 annual periods from 2013 to 2019. As of December 2019, the intensity stands at 0.6%, reflecting long-term investments of ₩1.03 Billion against total assets of ₩183.87 Billion KRW. For the complete balance sheet picture, see Samil Pharm total assets.

Annual Long-term Investment Intensity for Samil Pharm (2013–2019)

The table below presents the year-by-year Long-term Investment Intensity for Samil Pharm from 2013 to 2019, covering 7 annual filings. Each row shows total assets, long-term investments, the intensity percentage, and the change in percentage points compared to the prior year. Read 000520 liabilities breakdown for a breakdown of total debt and financial obligations.

Year LT Investment Intensity LT Investments (KRW) Total Assets Change (pp)
2019 0.6% ₩1.03 Billion ₩183.87 Billion ▼ -0.7 pp
2018 1.3% ₩1.88 Billion ₩147.95 Billion ▲ +0.5 pp
2017 0.7% ₩1.01 Billion ₩135.48 Billion ▼ -0.3 pp
2016 1.1% ₩1.09 Billion ₩101.00 Billion ▼ 0.0 pp
2015 1.1% ₩1.09 Billion ₩99.31 Billion ▼ -1.4 pp
2014 2.5% ₩2.75 Billion ₩108.29 Billion ▲ +2.5 pp
2013 0.1% ₩71.88 Million ₩115.71 Billion
pp = percentage points